NBY vs ULTA · $51.9M cap vs P/E 17, rev $3.04B
NovaBay Pharmaceuticals Inc (NBY) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
NBY does not have a complete income-statement cache yet.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
NBY currently screens at market cap $51.9M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the NBY and ULTA stock pages for the full models.
Not investment advice.